CSI Market
Sign In | Register

Definium Therapeutics Inc (DFTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access DFTX quarterly Balance Sheets →
From Definium Therapeutics Inc through Dec 31 2020, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2020)
Assets
Cash & cash equivalent257.84
Short-term Investments, Total153.76
Cash & Short-term Investments410.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.73
Total Current Assets419.32
Goodwill net19.92
Intangible Assets0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.86
Total Assets440.10
Liabilities
Accounts Payable, Current AC5.35
Accrued Liabilities, Current AC20.45
Other Liabilities, Current0.00
Total Current Liabilities66.70
Long-term debt40.58
Total Long-term Debt40.58
Other liabilities, Noncurrent0.50
Financing Warrants Liability40.91
Total Liabilities107.77
Stockholders' Equity
Additional Paid In Capital Common Stock913.91
Retained Earnings / Accumulated Deficit-582.67
Accumulated Other Comprehensive Income0.00
Other Equity1.09
Common Stockholder's Equity332.33
Total Stockholder's Equity332.33
Liabilities & Stockholder's Equity440.10
4 historic quarters locked

Sign in to unlock the full Definium Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Definium Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: dftx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-076742

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.